Login or sign up
For business
Average ratingAverage
3.9/ 5

Based on 8 reviews

525%
438%
338%
20%
10%
Ask AI

Ask AI about Hepatera

Generated with AI from 8 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Benjamin Willis
Reviews 1

I recently used a company's product and I must say, I was impressed. The quality and effectiveness of the product exceeded my expectations. The website was user-friendly and the customer service was very helpful. I highly recommend giving their products a try!

Jefferey Deinnocentis
Reviews 1

I had a great experience with Hepatera! The company website was easy to navigate and their customer service was excellent. They responded quickly to my inquiries and provided clear and detailed answers. The product itself was of top-notch quality and delivered on time. I highly recommend Hepatera for anyone looking for reliable and effective products.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Hepatera

Hepatera is a Russian biotechnology company founded in 2011. The main activity of the company is the search for and evaluation of promising drug candidates, as well as development and bringing to the Russian market safe and effective drugs for the treatment of liver diseases. First product (Myrcludex B) is aimed at the treatment of chronic hepatitis B and D. Myrcludex B is based on the research of the University Ruprecht-Karls-Universität Heidelberg, and is being developed in the framework of international cooperation with the biotechnology company MYR, GmbH (Germany).

Since December 2011 Hepatera has become resident of Biomedical cluster of Skolkovo innovation center.